Feature|Articles|October 22, 2026

Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology

Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.

Background. Electronic health record-to-electronic data capture (EHR-to-EDC), commonly referred to as eSource, has emerged as a transformative approach for reducing manual data transcription, improving data quality, and decreasing operational burden in clinical trials. While numerous implementation studies have demonstrated promising operational benefits, broader adoption has been constrained by the lack of standardized methodologies capable of generating reproducible and comparable evidence across sponsors, investigational sites, and technology platforms. To address this gap, the European Institute for Innovation through Health Data (i~HD) eSource Scale-Up Task Force developed a harmonized key performance indicator (KPI) framework together with standardized methodologies for measuring implementation outcomes. This study presents the first multi-site validation of the Task Force's standardized clinical research coordinator (CRC) Satisfaction methodology.

Related to this article

© putilov_denis - © putilov_denis - stock.adobe.com
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.